{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:58:09Z","timestamp":1761947889825,"version":"3.37.3"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1124\/jpet.113.207209","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T01:01:44Z","timestamp":1379034104000},"page":"542-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nonhuman Primates: Translational Models for Predicting Antipsychotic-Induced Movement Disorders"],"prefix":"10.1016","volume":"347","author":[{"given":"Roger D.","family":"Porsolt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Castagn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Virley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.207209_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1176\/appi.psy.47.1.70","article-title":"Quetiapine in the treatment of behavioral disturbances in patients with Huntington\u2019s disease","volume":"47","author":"Alpay","year":"2006","journal-title":"Psychosomatics"},{"key":"10.1124\/jpet.113.207209_bib2","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/sj.npp.1300151","article-title":"The muscarinic M1\/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys","volume":"28","author":"Andersen","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.113.207209_bib3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00174678","article-title":"GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias","volume":"94","author":"Andersson","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.113.207209_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/11632020-000000000-00000","article-title":"Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-world trials taught us?","volume":"26","author":"Attard","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1124\/jpet.113.207209_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbr.2009.05.015","article-title":"Differences among conventional, atypical and novel putative D(2)\/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys","volume":"203","author":"Auclair","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.113.207209_bib7","doi-asserted-by":"crossref","first-page":"e25588","DOI":"10.1371\/journal.pone.0025588","article-title":"Long-stay psychiatric patients: a prospective study revealing persistent antipsychotic-induced movement disorder","volume":"6","author":"Bakker","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1124\/jpet.113.207209_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1744-9081-8-12","article-title":"Relevance of animal models to human tardive dyskinesia","volume":"8","author":"Blanchet","year":"2012","journal-title":"Behav Brain Funct"},{"key":"10.1124\/jpet.113.207209_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00702-005-0297-1","article-title":"The substituted (S)-3-phenylpiperidine (-)-OSU6162 reduces apomorphine- and amphetamine-induced behaviour in Cebus apella monkeys","volume":"113","author":"Brandt-Christensen","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1124\/jpet.113.207209_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00432375","article-title":"Dopamine, acetylcholine, and GABA effects in acute dystonia in primates","volume":"70","author":"Casey","year":"1980","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF02245613","article-title":"Behavioral effects of sertindole, risperidone, clozapine and haloperidol in Cebus monkeys","volume":"124","author":"Casey","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s002130100808","article-title":"The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates","volume":"157","author":"Casey","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 9","key":"10.1124\/jpet.113.207209_bib13","first-page":"25","article-title":"Pathophysiology of antipsychotic drug-induced movement disorders","volume":"65","author":"Casey","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.113.207209_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1054-3589(08)57010-4","article-title":"Preclinical behavioral models for predicting antipsychotic activity","volume":"57","author":"Castagn\u00e9","year":"2009","journal-title":"Adv Pharmacol"},{"key":"10.1124\/jpet.113.207209_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/278059a0","article-title":"Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months","volume":"278","author":"Clow","year":"1979","journal-title":"Nature"},{"year":"1980","series-title":"Maniement des M\u00e9dicaments Psychotropes","author":"Deniker","key":"10.1124\/jpet.113.207209_bib16"},{"key":"10.1124\/jpet.113.207209_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF02806012","article-title":"Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol","volume":"127","author":"Egan","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0091-3057(97)00314-6","article-title":"The common marmoset (Callithrix jacchus) as a model for neuroleptic-induced acute dystonia","volume":"58","author":"Fukuoka","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.113.207209_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0278-5846(90)90068-R","article-title":"Remoxipride, a new selective D2 antagonist, and haloperidol in cebus monkeys","volume":"14","author":"Gerlach","year":"1990","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.113.207209_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/10401230209147398","article-title":"Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria","volume":"14","author":"Gerlach","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"10.1124\/jpet.113.207209_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00426838","article-title":"Haloperidol-induced tardive dyskinesia in monkeys","volume":"50","author":"Gunne","year":"1976","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00433548","article-title":"A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia","volume":"63","author":"Gunne","year":"1979","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12603-012-0057-5","article-title":"Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?","volume":"16","author":"Gurevich","year":"2012","journal-title":"J Nutr Health Aging"},{"key":"10.1124\/jpet.113.207209_bib24","first-page":"1536","article-title":"[Neuroleptics and the extrapyramidal system]","volume":"28","author":"Haase","year":"1978","journal-title":"Arzneimittelforschung"},{"issue":"5Suppl","key":"10.1124\/jpet.113.207209_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0269881111424929","article-title":"Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons","volume":"26","author":"Haddad","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.113.207209_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01252800","article-title":"Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias","volume":"58","author":"H\u00e4ggstr\u00f6m","year":"1983","journal-title":"J Neural Transm"},{"key":"10.1124\/jpet.113.207209_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0447.1984.tb06862.x","article-title":"Effects of sulpiride on persistent neuroleptic-induced dyskinesia in monkeys","volume":"311","author":"H\u00e4ggstr\u00f6m","year":"1984","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1124\/jpet.113.207209_bib29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7326\/0003-4819-157-7-201210020-00525","article-title":"Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis","volume":"157","author":"Hartling","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.113.207209_bib30","doi-asserted-by":"crossref","unstructured":"Hayes E, Hubert I, Oktarina R, Budiarsa N, Iskandriati D, Pushett D, and Virley D (2012) EPS liability in the cynomolgus monkey: effects of acute haloperidol and olanzapine administration in drug na\u00efve animals. Poster presented at the Safety Pharmacology Society Meeting; 2012 October 1\u20134; Phoenix, AZ. Safety Pharmacology Society, Reston, VA.","DOI":"10.1016\/j.vascn.2013.01.030"},{"issue":"Suppl","key":"10.1124\/jpet.113.207209_bib31","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF00442551","article-title":"The history of clozapine","volume":"99","author":"Hippius","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib32","first-page":"232","article-title":"Neuropharmacological profile of MD 790501, a new benzamide derivative","volume":"264","author":"Jalfre","year":"1983","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1124\/jpet.113.207209_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archpsyc.1995.03950210050010","article-title":"Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients","volume":"52","author":"Jeste","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.113.207209_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/YIC.0b013e3283407775","article-title":"Risperidone long-acting injection and Huntington\u2019s disease: case series with significant psychiatric and behavioural symptoms","volume":"26","author":"Johnston","year":"2011","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1124\/jpet.113.207209_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01245143","article-title":"Suppression of neuroleptic-induced persistent abnormal movements in Cebus apella monkeys by enantiomers of 3-PPP","volume":"74","author":"Kovacic","year":"1988","journal-title":"J Neural Transm"},{"key":"10.1124\/jpet.113.207209_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF00426645","article-title":"Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects","volume":"68","author":"Liebman","year":"1980","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib37","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.neuropharm.2010.10.014","article-title":"Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys","volume":"60","author":"Madsen","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.113.207209_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/jpet.104.080184","article-title":"Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action","volume":"313","author":"Maheux","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.207209_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/brain\/100.2.313","article-title":"Acute dystonia as an idiosyncratic response to neuroleptics in baboons","volume":"100","author":"Meldrum","year":"1977","journal-title":"Brain"},{"issue":"Suppl","key":"10.1124\/jpet.113.207209_bib40","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/BF00442554","article-title":"Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia","volume":"99","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00464570","article-title":"Progressive changes in the acute dyskinetic syndrome as a function of repeated elicitation in squirrel monkeys","volume":"77","author":"Neale","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s002130050993","article-title":"New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects","volume":"144","author":"Peacock","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s004060050090","article-title":"Extrapyramidal side effects during chronic combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys","volume":"249","author":"Peacock","year":"1999","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1124\/jpet.113.207209_bib44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.bp.111.101485","article-title":"Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs","volume":"200","author":"Peluso","year":"2012","journal-title":"Br J Psychiatry"},{"key":"10.1124\/jpet.113.207209_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00433494","article-title":"Neuroleptic-induced acute dyskinesias in rhesus monkeys","volume":"75","author":"Porsolt","year":"1981","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib46","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/0091-3057(82)90141-1","article-title":"Antiapomorphine and locomotor effects of neuroleptics in rhesus monkeys","volume":"17","author":"Porsolt","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.113.207209_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00426400","article-title":"Lack of tolerance to haloperidol-induced acute dyskinesias in rhesus monkeys","volume":"82","author":"Porsolt","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib48","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/jpet.110.166710","article-title":"Behavioral indices in antipsychotic drug discovery","volume":"333","author":"Porsolt","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.207209_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vascn.2013.03.004","article-title":"The usefulness of non-human primates in central nervous system safety pharmacology","volume":"68","author":"Porsolt","year":"2013","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/jpet.113.207209_bib50","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/pch\/16.9.590","article-title":"Treatment recommendations for extrapyramidal side effects associated with second-generation antipsychotic use in children and youth","volume":"16","author":"Pringsheim","year":"2011","journal-title":"Paediatr Child Health (Oxford)"},{"key":"10.1124\/jpet.113.207209_bib51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0149-7634(99)00069-X","article-title":"Animal models of acute drug-induced akathisia - a review","volume":"24","author":"Sachdev","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.113.207209_bib52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1254\/jphs.93.364","article-title":"Effect of a novel potential atypical antipsychotic drug, Y-931, in producing dystonia in cebus monkeys","volume":"93","author":"Shiigi","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.113.207209_bib53","first-page":"343","article-title":"Animal models of neuroleptic-induced acute dystonia","volume":"50","author":"Stewart","year":"1988","journal-title":"Adv Neurol"},{"key":"10.1124\/jpet.113.207209_bib54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","article-title":"The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?","volume":"26","author":"Turrone","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.113.207209_bib55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02244220","article-title":"Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia","volume":"101","author":"Waddington","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.113.207209_bib56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00492366","article-title":"Movement disorders induced in monkeys by chronic haloperidol treatment","volume":"53","author":"Weiss","year":"1977","journal-title":"Psychopharmacology (Berl)"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524288273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524288273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.207209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:19:38Z","timestamp":1739996378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524288273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0022356524288273"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.207209","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonhuman Primates: Translational Models for Predicting Antipsychotic-Induced Movement Disorders","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.207209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}